Goldman Sachs’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,500
Closed -$307K 5373
2019
Q4
$307K Buy
+4,500
New +$282K ﹤0.01% 4733
2016
Q2
Sell
-34,000
Closed -$1.53M 7126
2016
Q1
$1.53M Buy
+34,000
New +$1.21M ﹤0.01% 3721

Other funds holding INGN

Goldman Sachs's INGN Position: Q1 2026 in Review

Goldman Sachs reduced its Inogen (INGN) stake by 1.6% in Q1 2026, selling an estimated $56.6K and leaving 580,100 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4013.

Goldman Sachs first reported a position in INGN in Q2 2014 and has held it in 44 quarters since. The position peaked at $50.9M in Q3 2018. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Goldman Sachs held 580,100 shares of Inogen worth $3.59M as of Q1 2026.
  • Goldman Sachs sold 9,173 Inogen shares in Q1 2026, an estimated $56.6K.
  • Inogen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4013 holding.
  • Goldman Sachs first reported a position in Inogen in Q2 2014 and has held it in 44 quarters since.
  • Goldman Sachs's Inogen position peaked at $50.9M in Q3 2018.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.